Dosage forms useful for modifying conditions and functions associated with hearing loss and/or tinnitus

Number of patents in Portfolio can not be more than 2000

United States of America Patent

PATENT NO 6524619
APP PUB NO 20020061870A1
SERIAL NO

09765974

Stats

ATTORNEY / AGENT: (SPONSORED)

Importance

Loading Importance Indicators... loading....

Abstract

See full text

The invention defines interdependent biofactors and biomolecules, and clinically useful formulations that are comprised of them. The active agents are demonstrated to be complementary in their physiologic functions especially as these relate to the quenching of free radicals and to the support of endothelial physiology, the reduction of hyperinsulinemia and improvements in vascular health. The active components of the invention are selected for inclusion in precise combinations specifically because they improve these various conditions and physiological functions, and by so doing reduce a variety of risks associated with hearing loss and tinnitus. The resulting enhancement of general systemic vascular health, improvement in local VIII.sup.th nerve vascular health, modulation of conditions surrounding blood fluid dynamics, the consequences of hyperinsulinemia, and improvements in free radical defenses, all reduce the potential for cochlear hair cell death and VIII.sup.th nerve atrophy, and the hearing loss and possible deafness that accompany them.

Loading the Abstract Image... loading....

First Claim

See full text

Family

Loading Family data... loading....

Patent Owner(s)

Patent OwnerAddress
CHRONORX LLCP O BOX 11207 ANCHORAGE AK 99511

International Classification(s)

  • [Classification Symbol]
  • [Patents Count]

Inventor(s)

Inventor Name Address # of filed Patents Total Citations
Pearson, Don C Lakewood, WA 20 482
Richardson, Kenneth T Anchorage, AK 21 495

Cited Art Landscape

Load Citation

Patent Citation Ranking

Forward Cite Landscape

Load Citation